Chephalon finalizes label revisions for Provigil Congress will not legislate generic biotech medications New York joins state lawsuits over Vioxx Chephalon warns Fentora prescribers about possible adverse effects FDA Approves Levaquin Short-Course Therapy Treatment Appeals court rules in favor of Novartis; stops Teva from selling generic Famvir for now Bayer Schering completes acquisition of Novartis' facility Purdue pays out over $7 million over OxyContin FDA approves new dosage of MedPointe's Soma Sanofi-Aventis offers update on its new products First Previous 2689 2690 2691 2692 2693 Next Last
